Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Gunji

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicityE Gorelik, Y Gunji, R B Herberman
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1991
[Immunosuppressive agents--advances of the developmental studies and the mode of action]T Ochiai, K Isono, Y Gunji, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Combination of immunosuppressive drugs for organ transplantationT Ochiai, Y Gunji, M Nagata, et al.
FEBS Letters|November 22, 2000
Shiga toxin activates p38 MAP kinase through cellular Ca(2+) increase in Vero cellsM Ikeda, Y Gunji, S Yamasaki, et al.
Surgical Endoscopy|September 1, 2005
Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancerH Hayashi, T Ochiai, H Shimada, et al.
Surgery Today|December 8, 2000
Gene therapy for cancerY Gunji, T Ochiai, H Shimada, et al.
The Journal of Pediatrics|November 1, 1988
Neonatal hyperlactacidemia and hypoglycemia caused by delayed maturation of fructose-1,6-diphosphatase activityH Kodama, I Okabe, Y Gunji, et al.
Transplantation Proceedings|December 1, 1991
Effective and safe use of FK 506: combination treatment with rapamycin or RS-61443 in experimental organ transplantationT Ochiai, Y Gunji, M Nagata, et al.
Oncogene|February 2, 1999
Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation responseE I Korpelainen, M Kärkkäinen, Y Gunji, et al.
Pediatric Neurology|March 1, 1992
P300 as indicator of effects of prophylactic cranial radiationT Sato, M Miyao, H Muchi, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicityE Gorelik, Y Gunji, R B Herberman
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1991
[Immunosuppressive agents--advances of the developmental studies and the mode of action]T Ochiai, K Isono, Y Gunji, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Combination of immunosuppressive drugs for organ transplantationT Ochiai, Y Gunji, M Nagata, et al.
FEBS Letters|November 22, 2000
Shiga toxin activates p38 MAP kinase through cellular Ca(2+) increase in Vero cellsM Ikeda, Y Gunji, S Yamasaki, et al.
Surgical Endoscopy|September 1, 2005
Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancerH Hayashi, T Ochiai, H Shimada, et al.
Surgery Today|December 8, 2000
Gene therapy for cancerY Gunji, T Ochiai, H Shimada, et al.
The Journal of Pediatrics|November 1, 1988
Neonatal hyperlactacidemia and hypoglycemia caused by delayed maturation of fructose-1,6-diphosphatase activityH Kodama, I Okabe, Y Gunji, et al.
Transplantation Proceedings|December 1, 1991
Effective and safe use of FK 506: combination treatment with rapamycin or RS-61443 in experimental organ transplantationT Ochiai, Y Gunji, M Nagata, et al.
Oncogene|February 2, 1999
Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation responseE I Korpelainen, M Kärkkäinen, Y Gunji, et al.
Pediatric Neurology|March 1, 1992
P300 as indicator of effects of prophylactic cranial radiationT Sato, M Miyao, H Muchi, et al.
Pageof 9